OSCIMIN
NDC 68047-253, Hyoscyamine Sulfate, tablet, orally disintegrating, from Larken Laboratories, Inc..
- Product NDC
- 68047-253
- Status
- Listed
- Labeler
- Larken Laboratories, Inc.
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68047-253 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYOSCYAMINE SULFATE.125 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68047-253-01 | 68047025301 | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68047-253-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2d5fa637-0696-40fe-9bc1-fcb6f07a50f6NADAC price for package 68047025301
GET /v1/drugs/nadac/68047025301
Use it
Look up 68047-253 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68047-253 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68047-253. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.